Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) have been given a consensus rating of “Buy” by the six ratings firms that are presently covering the firm, MarketBeat reports. Four research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $12.13.
Several equities analysts recently weighed in on the stock. Oppenheimer cut their price objective on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a research report on Monday, October 21st. Canaccord Genuity Group reduced their price objective on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Roth Mkm lowered their target price on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, September 11th. Finally, Lake Street Capital reduced their price target on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, September 11th.
Get Our Latest Stock Report on Bioceres Crop Solutions
Hedge Funds Weigh In On Bioceres Crop Solutions
Bioceres Crop Solutions Price Performance
Shares of NASDAQ:BIOX opened at $7.00 on Monday. The company’s fifty day moving average is $7.14 and its two-hundred day moving average is $9.41. The company has a market cap of $439.95 million, a P/E ratio of 350.18 and a beta of 0.49. Bioceres Crop Solutions has a 12-month low of $5.71 and a 12-month high of $14.05. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.37.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last issued its earnings results on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The business had revenue of $92.60 million during the quarter, compared to analyst estimates of $117.15 million. During the same quarter in the prior year, the company earned ($0.07) EPS. Equities analysts expect that Bioceres Crop Solutions will post 0.12 earnings per share for the current fiscal year.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Featured Articles
- Five stocks we like better than Bioceres Crop Solutions
- What is a Death Cross in Stocks?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- When to Sell a Stock for Profit or Loss
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.